We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+14.55%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$48.4B
AUM Growth
+$6.98B
Cap. Flow
+$2.25B
Cap. Flow %
4.65%
Top 10 Hldgs %
32.53%
Holding
907
New
61
Increased
512
Reduced
260
Closed
23

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$156M
2
AAPL icon
Apple
AAPL
+$146M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
AMZN icon
Amazon
AMZN
+$112M
5
META icon
Meta Platforms (Facebook)
META
+$102M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$112M
2
CRH icon
CRH
CRH
+$63M
3
BAH icon
Booz Allen Hamilton
BAH
+$53.1M
4
ADSK icon
Autodesk
ADSK
+$49.6M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$46.5M

Sector Composition

Rank Sector Weight
1 Technology 33.06%
2 Financials 14.46%
3 Consumer Discretionary 10.73%
4 Communication Services 9.55%
5 Healthcare 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGX icon
701
Argan
AGX
$7.98B
$509K ﹤0.01%
2,309
-2,853
-55% -$514K
UNM icon
702
Unum
UNM
$13.8B
$507K ﹤0.01%
+6,281
New +$496K
CWCO icon
703
Consolidated Water Co
CWCO
$469M
$507K ﹤0.01%
+16,891
New +$437K
PIPR icon
704
Piper Sandler
PIPR
$5.14B
$506K ﹤0.01%
7,284
-2,028
-22% -$126K
CR icon
705
Crane Co
CR
$13.1B
$506K ﹤0.01%
2,664
-1,217
-31% -$202K
MC icon
706
Moelis & Co
MC
$4.98B
$505K ﹤0.01%
8,097
+1,373
+20% +$77.1K
NMIH icon
707
NMI Holdings
NMIH
$3.25B
$504K ﹤0.01%
11,954
-5,326
-31% -$200K
INGR icon
708
Ingredion
INGR
$6.38B
$504K ﹤0.01%
+3,715
New +$502K
PAX icon
709
Patria Investments
PAX
$1.72B
$503K ﹤0.01%
35,806
-17,723
-33% -$213K
HDSN
710
Hudson Technologies
HDSN
$267M
$503K ﹤0.01%
61,899
-41,373
-40% -$284K
VMI icon
711
Valmont Industries
VMI
$9.44B
$502K ﹤0.01%
+1,537
New +$471K
BLBD icon
712
Blue Bird Corp
BLBD
$2.41B
$501K ﹤0.01%
11,615
-6,038
-34% -$230K
APAM icon
713
Artisan Partners
APAM
$2.79B
$499K ﹤0.01%
11,260
-3,348
-23% -$134K
STOK icon
714
Stoke Therapeutics
STOK
$1.82B
$499K ﹤0.01%
+43,955
New +$417K
BKE icon
715
Buckle
BKE
$2.19B
$497K ﹤0.01%
10,952
-4,439
-29% -$175K
APPF icon
716
AppFolio
APPF
$5.84B
$496K ﹤0.01%
2,153
-671
-24% -$146K
OSPN icon
717
OneSpan
OSPN
$562M
$495K ﹤0.01%
29,640
-7,805
-21% -$121K
NSSC icon
718
Napco Security Technologies
NSSC
$1.28B
$494K ﹤0.01%
16,638
-8,150
-33% -$210K
AXS icon
719
AXIS Capital
AXS
$8.59B
$494K ﹤0.01%
+4,757
New +$473K
LNTH icon
720
Lantheus
LNTH
$6.82B
$492K ﹤0.01%
6,015
-479
-7% -$42.1K
KRYS icon
721
Krystal Biotech
KRYS
$9.88B
$491K ﹤0.01%
3,575
+319
+10% +$46.9K
MANH icon
722
Manhattan Associates
MANH
$8.97B
$491K ﹤0.01%
2,487
-37,595
-94% -$6.82M
RLI icon
723
RLI Corp
RLI
$5.68B
$490K ﹤0.01%
6,781
-1,295
-16% -$97.1K
AIZ icon
724
Assurant
AIZ
$13.7B
$489K ﹤0.01%
2,477
-31,349
-93% -$6.16M
LAUR icon
725
Laureate Education
LAUR
$5.18B
$488K ﹤0.01%
+20,876
New +$448K

Similar funds

Aviva's Q2 2025 Portfolio in Review

As of Q2 2025, Aviva held 907 positions worth $48.4B, up 17% from $41.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Aviva deployed $2.25B of net new capital in Q2 2025, opening 61 new positions and adding to 512 existing holdings. Its largest new stake was Tapestry: 769,981 shares worth $67.6M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $112M trimmed.

  • Aviva's largest Q2 2025 buy was Tapestry: 769,981 shares worth $67.6M.
  • Aviva added most to Microsoft in Q2 2025, an estimated $156M increase.
  • Aviva's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $112M.
  • Aviva fully exited Discover Financial Services in Q2 2025, selling an estimated $41.6M.
  • Aviva's ten largest holdings make up 33% of its $48.4B portfolio in Q2 2025.
  • Aviva opened 61 new positions and closed 23 in Q2 2025.
  • Aviva's portfolio value rose 17% quarter-over-quarter to $48.4B.

Based on Aviva's 13F filing for Q2 2025, filed 7 Aug 2025.